Physician profile
Anil Thaker
NPI 1982628962
$4,049.69
in general payments reported to CMS, 2019-2025
28 companies · $1,168 in 2025
The $1,168 reported for 2025 was more than what 91% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $355 · 2021: $338 · 2022: $419 · 2023: $411 · 2024: $874 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,452.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $797.18 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $593.16 | 2019-2025 | Mounjaro, Kisunla, Zepbound |
| Astellas Pharma US INC | $399.78 | 2019-2024 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $269.92 | 2019-2020 | |
| Amgen INC. | $201.94 | 2019-2025 | Repatha, Otezla |
| Medtronic, INC. | $195.36 | 2023-2025 | Hawkone, Abre |
| Sumitomo Pharma America, INC. | $150.03 | 2024-2025 | Gemtesa |
| Abbott Laboratories | $146.37 | 2021-2025 | Freestyle Libre 3, Afinion 2 |
| Glaxosmithkline, LLC. | $130.41 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Exact Sciences Corporation | $128.57 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $94.54 | 2019 | |
| Eli Lilly and Company | $92.53 | 2023 | |
| Pfizer INC. | $89.89 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $84.30 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $69.90 | 2021-2023 | Breztri |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $68.34 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.01 | 2019-2022 | |
| Pulmonx Corporation | $62.73 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Dynavax Technologies Corporation | $61.23 | 2021-2024 | Heplisav-B |
| Cranial Technologies, INC | $55.86 | 2019-2022 | |
| Irhythm Technologies, INC. | $53.56 | 2024 | Zio Xt Patch, Zio Monitor |
| Abbvie INC. | $46.98 | 2022 | |
| Inspire Medical Systems, INC. | $36.75 | 2024-2025 | Inspire |
| Allergan, INC. | $34.05 | 2020 | |
| Sanofi-Aventis U.S. LLC | $33.37 | 2021-2025 | |
| Genentech USA, INC. | $30.19 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $28.49 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $28.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Thaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.